ADVFN US – Market Content Editor

  • IonQ Best Paper Awards Highlight Quantum Advances in AI, Hybrid Computing and Life Sciences

    IonQ Best Paper Awards Highlight Quantum Advances in AI, Hybrid Computing and Life Sciences

    IonQ received four Best Paper Awards ahead of IEEE Quantum Week 2026, highlighting research with commercial and institutional partners across artificial intelligence, engineering and life sciences. Key Investor Takeaways Why IONQ Stock Is in Focus IonQ received four of the 27 Best Paper honors awarded ahead of IEEE Quantum Week 2026, with the company’s research…

  • American Fusion Texatron Testing Results Show Hotter, Denser and Stable Toroidal Plasma

    American Fusion Texatron Testing Results Show Hotter, Denser and Stable Toroidal Plasma

    American Fusion says its latest pulsed magnetic-field experiments produced hotter and denser plasma while maintaining toroidal stability, but quantitative measurements and independent validation remain future steps. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion reported new Texatron testing results from experiments using high-voltage capacitor banks to generate short, high-intensity magnetic-field pulses that…

  • Rocket Pharmaceuticals Shares Rise 8% After FDA Alignment on Danon Disease Trial

    Rocket Pharmaceuticals Shares Rise 8% After FDA Alignment on Danon Disease Trial

    Rocket Pharmaceuticals (NASDAQ:RCKT) shares rose 8% on Tuesday after the company said it reached alignment with the US Food and Drug Administration on the pivotal Phase 2 trial of RP-A501 for Danon disease. The FDA confirmed a pivotal efficacy population of 12 patients, including the first three patients treated under the study’s modified protocol, according…

  • Tenet Healthcare Shares Fall 2.3% After Director Sells $2.63 Million of Stock

    Tenet Healthcare Shares Fall 2.3% After Director Sells $2.63 Million of Stock

    Tenet Healthcare Corporation (NYSE:THC) shares fell 2.3% in premarket trading on Tuesday after a regulatory filing showed that director Richard Mark sold 10,000 shares in the healthcare company. Mark sold the shares on September 10 at a weighted average price of $263.42 each, according to a Form 4 filing with the US Securities and Exchange…

  • Etsy Shares Rise 2.9% as Oppenheimer Upgrades Stock to Outperform

    Etsy Shares Rise 2.9% as Oppenheimer Upgrades Stock to Outperform

    Etsy (NASDAQ:ETSY) shares rose 2.9% in premarket trading on Tuesday after Oppenheimer analyst Jason Helfstein upgraded the online marketplace to Outperform from Perform and set a $90 price target. Helfstein cited potential benefits from artificial intelligence search, product improvements and changes in app engagement and conversion. The analyst said an analysis of SimilarWeb website traffic…

  • BioVie Shares Fall 9.7% After Long COVID Trial Misses Statistical Significance in Full Population

    BioVie Shares Fall 9.7% After Long COVID Trial Misses Statistical Significance in Full Population

    BioVie (NASDAQ:BIVI) shares fell nearly 9.7% in premarket trading after the company reported results from its Phase 2 ADDRESS-LC trial evaluating bezisterim for neurological symptoms associated with Long COVID. The study did not achieve statistical significance on any of its 22 clinical outcome measures in the full intent-to-treat population of 203 patients. The trial was…

  • Aeluma Shares Rise 7% After Sumitomo Chemical Photonics Manufacturing Agreement

    Aeluma Shares Rise 7% After Sumitomo Chemical Photonics Manufacturing Agreement

    Aeluma (NASDAQ:ALMU) shares rose 7% to $13.42 in premarket trading on Tuesday after the company announced an agreement with Sumitomo Chemical Advanced Technologies to jointly develop and manufacture photonics wafers for the artificial intelligence data communications market. Under the agreement, the companies will use Sumitomo Chemical Advanced Technologies’ existing metal-organic chemical vapour deposition, or MOCVD,…

  • BlossomHill Therapeutics Shares Rise 4.4% After BH-30643 Trial Update

    BlossomHill Therapeutics Shares Rise 4.4% After BH-30643 Trial Update

    BlossomHill Therapeutics (NASDAQ:BLSM) shares rose 4.4% in premarket trading after the company presented updated clinical data for investigational drug BH-30643 at the 2026 World Conference on Lung Cancer in Seoul, South Korea. The data came from the Phase 1/2 SOLARA trial evaluating BH-30643 in patients with EGFR C797S-positive non-small cell lung cancer, or NSCLC. Among…

  • Flex Shares Rise 2.6% as Company Names Planned Axiom Solutions Spin-Off

    Flex Shares Rise 2.6% as Company Names Planned Axiom Solutions Spin-Off

    Flex (NASDAQ:FLEX) shares rose 2.6% in premarket trading after the company named its planned cloud and power infrastructure spin-off Axiom Solutions International and filed a preliminary Form 10 registration statement with the US Securities and Exchange Commission. The filing represents another step in Flex’s previously announced separation plan. The transaction is expected to be completed…

  • Micron Demonstrates 512GB DDR5 Memory Module for Server Platforms

    Micron Demonstrates 512GB DDR5 Memory Module for Server Platforms

    Micron Technology (NASDAQ:MU) announced on September 15, 2026, that it has demonstrated a 512GB DDR5 registered dual in-line memory module, or RDIMM, across multiple server platforms. The company described the 512GB DDR5 RDIMM as the first module of its kind. It uses vertical interconnect packaging technology that stacks DRAM dies connected through through-silicon vias, or…